Literature DB >> 11549660

Allelotyping of follicular thyroid carcinoma: frequent allelic losses in chromosome arms 7q, 11p, and 22q.

Y Kitamura1, K Shimizu, K Ito, S Tanaka, M Emi.   

Abstract

The genetic mechanisms involved in development of follicular thyroid carcinoma are poorly understood, although allelic losses (LOH) in this type of tumor have been reported in small panels of follicular thyroid carcinomas examined in earlier studies. To clarify the real frequency of allelic loss we carried out a genome-wide allelotyping study of 66 follicular thyroid carcinomas using 39 microsatellite markers representing all nonacrocentric autosomal arms. The mean frequency of LOH was 9.2%, and the mean fractional allelic loss was 0.09. The most frequent allelic losses were detected in 7q (28%), 11p (28%), and 22q (41%). When we compared these results with our previous allelotyping studies using identical markers in other types of thyroid cancers, the 9.2% mean frequency of allelic loss detected in follicular thyroid carcinomas was higher than that in papillary thyroid carcinomas (3%), but not as high as that detected in anaplastic thyroid carcinomas (20%). Frequent allelic losses of markers on chromosomes 7q, 11p, and 22q suggest locations to examine for the presence of suppressor genes associated with the development of follicular thyroid carcinoma.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11549660     DOI: 10.1210/jcem.86.9.7853

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Head and neck manifestations of 22q11.2 deletion syndromes.

Authors:  Tal Marom; Yehudah Roth; Abraham Goldfarb; Udi Cinamon
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-08-23       Impact factor: 2.503

2.  Poly r(C) binding protein (PCBP) 1 expression is regulated at the post-translation level in thyroid carcinoma.

Authors:  Ming-Peng Zhang; Wei-San Zhang; Jin Tan; Ming-Hui Zhao; Lin-Juan Lian; Jie Cai
Journal:  Am J Transl Res       Date:  2017-02-15       Impact factor: 4.060

3.  Poly r(C) binding protein (PCBP) 1 is a negative regulator of thyroid carcinoma.

Authors:  Mingpeng Zhang; Xin Wang; Jin Tan; Minghui Zhao; Linjuan Lian; Weisan Zhang
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

4.  Metastatic phenotype is regulated by estrogen in thyroid cells.

Authors:  Shilpi Rajoria; Robert Suriano; Arulkumaran Shanmugam; Yushan Lisa Wilson; Stimson P Schantz; Jan Geliebter; Raj K Tiwari
Journal:  Thyroid       Date:  2010-01       Impact factor: 6.568

5.  New prognostic scales LAST-1 and LAST-2: supporting prediction and staging of thyroid cancer.

Authors:  Andrzej J Lachinski; Tomasz Stefaniak; Jarek Kobiela; Saxon Connor; Zbigniew Gruca; Zbigniew Sledzinski
Journal:  World J Surg       Date:  2006-03       Impact factor: 3.352

6.  The loss of the p53 activator HIPK2 is responsible for galectin-3 overexpression in well differentiated thyroid carcinomas.

Authors:  Luca Lavra; Cinzia Rinaldo; Alessandra Ulivieri; Emidio Luciani; Paolo Fidanza; Laura Giacomelli; Carlo Bellotti; Alberto Ricci; Maria Trovato; Silvia Soddu; Armando Bartolazzi; Salvatore Sciacchitano
Journal:  PLoS One       Date:  2011-06-17       Impact factor: 3.240

Review 7.  American Head and Neck Society Endocrine Surgery Section and International Thyroid Oncology Group consensus statement on mutational testing in thyroid cancer: Defining advanced thyroid cancer and its targeted treatment.

Authors:  David C Shonka; Alan Ho; Ashish V Chintakuntlawar; Jessica L Geiger; Jong C Park; Nagashree Seetharamu; Sina Jasim; Amr H Abdelhamid Ahmed; Keith C Bible; Marcia S Brose; Maria E Cabanillas; Kirsten Dabekaussen; Louise Davies; Dora Dias-Santagata; James A Fagin; William C Faquin; Ronald A Ghossein; Raj K Gopal; Akira Miyauchi; Yuri E Nikiforov; Matthew D Ringel; Bruce Robinson; Mabel M Ryder; Eric J Sherman; Peter M Sadow; Jennifer J Shin; Brendan C Stack; R Michael Tuttle; Lori J Wirth; Mark E Zafereo; Gregory W Randolph
Journal:  Head Neck       Date:  2022-03-11       Impact factor: 3.821

8.  Poorly differentiated and anaplastic thyroid carcinomas: chromosomal and oligo-array profile of five new cell lines.

Authors:  R F Rodrigues; L Roque; T Krug; V Leite
Journal:  Br J Cancer       Date:  2007-04-03       Impact factor: 7.640

9.  Chromosomal imbalances associated with anaplastic transformation of follicular thyroid carcinomas.

Authors:  R F Rodrigues; L Roque; J Rosa-Santos; O Cid; J Soares
Journal:  Br J Cancer       Date:  2004-01-26       Impact factor: 7.640

10.  Poly r(C) binding protein (PCBP) 1 expression is regulated by the E3 ligase UBE4A in thyroid carcinoma.

Authors:  Ming-Peng Zhang; Wei-San Zhang; Jin Tan; Ming-Hui Zhao; Lin-Juan Lian; Jie Cai
Journal:  Biosci Rep       Date:  2017-10-31       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.